Use of M-M-R II outside of the routinely recommended age range - a systematic literature review
InfectologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Human vaccines & immunotherapeutics
- Publicado em
- 15 jun 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Use of M-M-R II outside of the routinely recommended age range - a systematic literature review
Manjiri Pawaskar, Elvira Schmidt, Gary S Marshall, Jaime Fergie, Elizabeth Richardson, Louise Parks Saldutti, Se Li, Monika Neumann, Linnea Koller, Barbara Kuter
Descritores MeSH
- Rubella
- Measles
- Mumps
- Humans
- Immunization Schedule
- Infant
- Vaccines, Combined
- Aged, 80 and over
- Measles-Mumps-Rubella Vaccine
- Antibodies, Viral
Veja também
Estudos relacionados
- Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine): Clinical Trials of Healthy Children and Adults Published Between 2010 and 2019
- Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial
- Comparative analysis of immunogenicity of Chinese MMR and MR vaccines following primary vaccination in infants in Gansu Province
- Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina